Back to results
US 2003/0225032 A1Published application
Pharmaceutical composition
AssigneeTaisho Pharmaceutical Co., Ltd.
InventorsShusei Ito, Akio Miwa, Mari Nakano
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical composition comprising N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and sulfobutyl ether β-cyclodextrin or a salt thereof, wherein sulfobutyl ether β-cyclodextrin increases the solubility of N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and improves the photostability.
Claims3
A pharmaceutical composition which comprises N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and sulfobutyl ether β-cyclodextrin or a salt thereof.
Dependencies are inferred from the claim text.